INTERACTION OF APELIN, ELABELA AND NITRIC OXIDE IN SCHIZOPHRENIA PATIENTS; [INTERAKCIJA APELINA, ELABELA I AZOT OKSIDA KOD PACIJENATA KOJI BOLUJU OD ŠIZOFRENIJE]

ArticleAçık Erişim

Özet

Background: Apelin (APLN), elabela (ELA), and nitric oxide (NO) have effects on physiological and behavioural properties in biological systems. This study was designed to determine APLN, ELA and NO levels in schizophrenia patients and assess whether these molecules are of diagnostic value. Methods: A total of 33 schizophrenic patients and 32 ageand sex-adjusted healthy participants were included in the study. ELA, APLN and NO levels were measured using ELISA methods. Results: Although the ELA and NO levels of the patients were lower than the control group, APLN levels were higher (p = 0.039, p = 0.019, p = 0.048, respectively). There was a significant negative correlation between APLN levels and triglyceride (TG) and body mass index (BMI) levels (r =-0.426, p = < 0.001 and r =-0.330, p = 0.007, respec tively). Respectively, the areas under the receiver-operating characteristic (ROC) curves of the ELA/APLN, ELA/NO and APLN/NO ratios were 0.628, 0.590 and 0.709, 95% confident intervals (CI): 0.491–0.764, 0.450–0.730 and 0.579–0.840. Conclusions: Decreased levels of ELA and NO and increased APLN levels in schizophrenia suggest that these molecules may be involved in its etiopathology. The APLN/NO ratio also seems to show promise in the diagnosis of the disease and may be used in future. © 2020, Society of Medical Biochemists of Serbia. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13637Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.2478/jomb-2019-0029Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCatak, Zekiye
dc.contributor.authorKaya, Hilal
dc.contributor.authorKocdemir, Esra
dc.contributor.authorUgur, Kader
dc.contributor.authorGuzel, Saadet Pilten
dc.contributor.authorYardim, Meltem
dc.contributor.authorSahin, Ibrahim
dc.contributor.authorAgirbas, Esra Piril
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-10-18T20:28:28.283562624Z
dc.date.available2026-10-18T20:28:28.283562624Z
dc.date.issued2020
dc.description.abstractBackground: Apelin (APLN), elabela (ELA), and nitric oxide (NO) have effects on physiological and behavioural properties in biological systems. This study was designed to determine APLN, ELA and NO levels in schizophrenia patients and assess whether these molecules are of diagnostic value. Methods: A total of 33 schizophrenic patients and 32 ageand sex-adjusted healthy participants were included in the study. ELA, APLN and NO levels were measured using ELISA methods. Results: Although the ELA and NO levels of the patients were lower than the control group, APLN levels were higher (p = 0.039, p = 0.019, p = 0.048, respectively). There was a significant negative correlation between APLN levels and triglyceride (TG) and body mass index (BMI) levels (r =-0.426, p = < 0.001 and r =-0.330, p = 0.007, respec tively). Respectively, the areas under the receiver-operating characteristic (ROC) curves of the ELA/APLN, ELA/NO and APLN/NO ratios were 0.628, 0.590 and 0.709, 95% confident intervals (CI): 0.491–0.764, 0.450–0.730 and 0.579–0.840. Conclusions: Decreased levels of ELA and NO and increased APLN levels in schizophrenia suggest that these molecules may be involved in its etiopathology. The APLN/NO ratio also seems to show promise in the diagnosis of the disease and may be used in future. © 2020, Society of Medical Biochemists of Serbia. All rights reserved.
dc.identifier.doi10.2478/jomb-2019-0029
dc.identifier.eissn1452-8266
dc.identifier.endpage190
dc.identifier.issn1452-8258
dc.identifier.issue2
dc.identifier.pmcidPMC7526016
dc.identifier.pmid33033451
dc.identifier.scopus2-s2.0-85095886792
dc.identifier.startpage184
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13637
dc.identifier.volume39
dc.identifier.wosWOS:000543793500008
dc.language.isoen
dc.publisherSociety of Medical Biochemists of Serbia
dc.relation.ispartofJournal of Medical Biochemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectapelin
dc.subjectelabela
dc.subjectnitric oxide
dc.subjectschizophrenia
dc.titleINTERACTION OF APELIN, ELABELA AND NITRIC OXIDE IN SCHIZOPHRENIA PATIENTS; [INTERAKCIJA APELINA, ELABELA I AZOT OKSIDA KOD PACIJENATA KOJI BOLUJU OD ŠIZOFRENIJE]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus7
rdl.citation.wos8
rdl.departmentFirat University Medical School, (Firat Hormones Research Group), Medical Biochemistry, Elazig, Turkey + Erzincan Binali Yildirim University Medical School, Medical Biology, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)